Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations.
暂无分享,去创建一个
[1] Haiyu Wang,et al. Updated meta-analysis of the association between CYP2E1 RsaI/PstI polymorphisms and lung cancer risk in Chinese population. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[2] Yun Liu,et al. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[3] P. Wangikar,et al. Association of N‐acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug‐induced hepatotoxicity in Western India , 2013, Journal of gastroenterology and hepatology.
[4] A. Semlali,et al. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[5] H. Galehdari,et al. CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[6] L. Magno,et al. Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs , 2012, Molecular Diagnosis & Therapy.
[7] P. Lee,et al. Population data of six Alu insertions in indigenous groups from Sabah, Malaysia , 2012, Annals of human biology.
[8] W. El-Rifai,et al. Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer , 2012, PloS one.
[9] Xueqiong Wu,et al. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug‐induced hepatotoxicity in Chinese patients , 2012, Clinical and experimental pharmacology & physiology.
[10] M. Su,et al. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. , 2012, Cancer epidemiology.
[11] K. Fielding,et al. Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[12] Z. Kayaaltı,et al. Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population. , 2010, Alcohol.
[13] T. Chuang,et al. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[14] S. Gallinger,et al. Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[15] Qin Wang,et al. Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. , 2008, World journal of gastroenterology.
[16] M. A. Ferreira,et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. , 2007, Carcinogenesis.
[17] I. Ember,et al. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. , 2007, Anticancer research.
[18] S. Küry,et al. Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption , 2007, Cancer Epidemiology Biomarkers & Prevention.
[19] T. Wobbes,et al. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. , 2006, Mutation research.
[20] Danko Im,et al. Association of CYP2E1 gene polymorphism with predisposition to cancer development. , 2005 .
[21] Defeng Wu,et al. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. , 2005, Toxicology and applied pharmacology.
[22] J. McCord. Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.
[23] J. Zhuge,et al. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. , 2003, World journal of gastroenterology.
[24] P. Kandasami,et al. Gastric cancer in Malaysia: the need for early diagnosis. , 2003, The Medical journal of Malaysia.
[25] O. Lee,et al. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans , 2003, Journal of gastroenterology and hepatology.
[26] Ricarda Thier,et al. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine , 2003, International archives of occupational and environmental health.
[27] L. Cai,et al. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. , 2001, World journal of gastroenterology.
[28] J. Y. Park,et al. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. , 2001, Oral oncology.
[29] D. Lin,et al. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] M. Spitz,et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. , 1997, Carcinogenesis.
[31] M. A. García,et al. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians. , 1997, Age and ageing.
[32] H. Yamazaki,et al. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] M. Fujishima,et al. Pathological aspects of active oxygens/free radicals. , 1996, The Japanese journal of physiology.
[34] C. J. Chen,et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. , 1995, Gastroenterology.
[35] S. Anttila,et al. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.
[36] G. Toda,et al. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. , 1994, The American journal of gastroenterology.
[37] R. Rylander,et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population , 1993, FEBS letters.
[38] R. Kanamaru,et al. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer. , 1992, The Tohoku journal of experimental medicine.
[39] B. Lakkakula,et al. Functional PstI/RsaI polymorphisms in the CYP2E1 gene among south Indian populations. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[40] N. Andreollo,et al. Polymorphisms of GSTP 1 and GSTT 1 , but not of CYP 2 A 6 , CYP 2 E 1 or GSTM 1 , modify the risk for esophageal cancer in a western population , 2007 .
[41] V. Haufroid,et al. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene , 2002, International archives of occupational and environmental health.
[42] M. Spitz,et al. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] J. George,et al. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. , 1998, Seminars in hematology.
[44] M. Boutin,et al. Indigenous groups of Sabah : an annotated bibliography of linguistic and anthropological sources , 1984 .